Published: 08-11-2022

Full Issue

FDA_3.65

Editorial

Editorial

Thanakrish Prasertsarn

3

FDA_3.65

Review Article

Endotoxin Content Testing in Biological Products with Recombinant Factor C

Ekalak Songtan, Kanitta Phuwanartnaranubarn

4-11

FDA_3.65

Research Article

Effects of Promoting Rational Drug Use in Community: Model of Thonghlang Community, Ranong Province

Sawaluck Keeratihuttayakorn, Surachet Dechmanee

12-22

FDA_3.65

Method Development and Validation for Detecting Specific Bovine Adventitious Viruses Contaminated in Vero Cell Substrates

Supaporn Chumpol, Sukanlayanee Chaimee, Wereyamarst Jaroenkunathum, Supaporn Phumiamorn

23-33

FDA_3.65

Herbal Product Registration Situation on the Thai Food and Drug Administration’s Auto e-Permission in 2020

Siripran Chatratana, Surasak Saokaew

34-46

FDA_3.65

Import Refusal of Thai Food Exported to the United States of America in 2011-2020

Trakul Prommajak, Sasinud Kormartakun, Maneewan Maneekan, Chanita Poraha, Waraporn Kusalaruk, Suwalee Fong-in

47-61

FDA_3.65

Quality of Alcohol-based Hand Sanitiser for Donated During the Coronavirus Disease (COVID-19) Pandemic

Achiraya Choorich

62-73

FDA_3.65

Hazardous Cosmetics sell on Thailand’s e-marketplace Platform

Chawalin Inthong, Saowalak Nunseat, Monnapa Kaewboon, Panupong Puttarak

74-85

FDA_3.65

Reporting System of High-risk Drug Abuse of Thai Food and Drug Administration: A Case Study of Tramadol

Chananan Chomngamdee, Nilawan Upakdee

86-97

FDA_3.65